“Vår teknologi kan verkligen förändra sjukvården”
Bröstsmärta är en vanlig anledning till att söka vård. Men det är bara 10 procent av de som söker vård som till sist diagnostiseras med...
Patientrekrytering slutförd för den randomiserade kontrollerade multicenterstudien FILTER-SCAD
FILTER-SCAD-studien är en randomiserad kontrollerad klinisk prövning med fler än 2 000 patienter med misstänkta kranskärlssjukdomar (CA...
Patient enrollment completed in the FILTER-SCAD randomized controlled multi-center trial
The FILTER-SCAD study is a randomized controlled clinical trial including more than 2,000 patients with suspected coronary artery disea...
Acarix och American College of Cardiology tecknar strategiskt samarbete
American College of Cardiology (“ACC”) och Acarix har tecknat ett strategiskt samarbetsavtal med syfte att utveckla ett kliniskt progra...
Acarix and the American College of Cardiology announce strategic collaboration
The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to develop a clinic...
Acarix and the American College of Cardiology announce strategic collaboration
The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to develop a clinic...
Acarix presenterar på Redeye under temat Diagnostik
Den 27 september kl 11.30 kommer Helen Ljungdahl Round, VD på Acarix, att presentera bolagets senaste utveckling inom Diagnostik
Presen...
Acarix presents at the Redeye event, Theme: Diagnostics
On September 27 at 11.30 am CEST, Helen Ljungdahl Round, President and CEO at Acarix will present the company´s latest developments wit...
Helen Ljungdahl Round, President and CEO presents at Redeye event, Theme: Diagnostics
On September 27 at 9.00am CEST, Helen Ljungdahl Round, President and CEO at Acarix presented the company´s latest developments within d...
Highlights from the European Society of Cardiology Congress 2022
In the Special Session ‘Best of the European Heart Journal – Digital Health’ Simon Winther, MD, PhD, Gødstrup Hospital, Denmark was inv...
Acarix AB (publ) publicerar delårsrapport, januari – juni 2022
Stort intresse och positiv utveckling på den amerikanska marknaden
Vi kan nu konstatera att vår Go-To-Market strategi i USA börjat gene...
Acarix AB (publ) publishes Interim Report, January – June 2022
Significant interest and positive developments in the US market
We can now conclude that our Go-To-Market strategy in the USA has start...